Prabhtej Brara, MD
Cardiology · Santa Monica, CANPI 1215917752
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 788 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 44 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations. Among cardiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 788 payments — averaging $24.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- E.r. Squibb & Sons, L.L.C.$2K
- Abbott$2K
- Novartis$2K
- Johnson & Johnson$2K
- Amgen$1K
- plus $9K from 38 others
What the payments were for
- Food & beverage$19,236100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - STENTS$784
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$674
- JOT DX$527
- GENERAL ATHERECTOMY$397
- XIENCE SIERRA$365
- Xience Sierra Coronary Stent$188
- ONYX FRONTIER$149
- MAMBA$148
- Impella$147
- Mitra Clip system$145
- Edwards SAPIEN 3 Transcatheter Heart Valve$144
- BioMonitor$131
- IGT D Coronary$130
- ELIQUIS$124
- Pounce Thrombectomy System$120
- Pounce Venous Thrombectomy System$120
- Descovy$120
- (5091) Amb Mon & Diag Und$118
- Resolute$116
- Cardiva VASCADE MVP VVCS 6-12F$104
How this compares
$19,236 in reported general payments places this provider in the 90th percentile of 156 cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 215 | $226,188 |
| EntrestoSacubitril/Valsartan | 64 | $63,227 |
| Repatha SureclickEvolocumab | 48 | $47,157 |
| Praluent PenAlirocumab | 60 | $40,080 |
| XareltoRivaroxaban | 37 | $36,711 |
| JardianceEmpagliflozin | 11 | $8,673 |
| VytorinEzetimibe/Simvastatin | 11 | $4,350 |
| Nebivolol Hcl | 25 | $3,094 |
| Ranolazine ErRanolazine | 22 | $2,668 |
| Amiodarone Hcl | 64 | $2,283 |
| Rosuvastatin Calcium | 139 | $2,153 |
| Ezetimibe | 75 | $2,132 |
| Atorvastatin Calcium | 168 | $1,848 |
| Digoxin | 84 | $1,516 |
| Metoprolol Succinate | 107 | $1,464 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $848 | $226,188215 claims |
| NovartisEntresto | $1,679 | $63,22764 claims |
| Johnson & JohnsonXarelto | $1,641 | $36,71137 claims |
| Boehringer IngelheimJardiance | $230 | $8,67311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 156 cardiology providers in California.
Other cardiology in Santa Monica
- Emily CrandallSanta Monica$11K
- Daniel WohlgelernterSanta Monica$871
- Norman LeporBeverly Hills$1.9M
- Sanjay KaulLos Angeles$1.1M
- Ramtin AgahMountain View$361K
- Jamshid MaddahiLos Angeles$59K
- Bipin JoshiFresno$51K
- Anil ShahSanta Ana$49K
- Thomas KimSanta Ana$47K
- Hooman MadyoonLos Angeles$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.